Unlock the Editor’s Digest without cost
Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication.
Temasek and Warburg Pincus are getting ready to place healthcare provide chain administration firm World Healthcare Change up on the market, aiming at a valuation of virtually $5bn, in accordance with individuals accustomed to the matter.
GHX, through which the Singaporean government-backed funding fund owns a majority stake and the US private equity group the rest, was working with advisers on a sale course of, which might lead to a partial or full- stake sale, the individuals mentioned. GHX is anticipating to obtain formal bids within the second half of the 12 months.
The public sale is the most recent instance of funding funds seeking to offload belongings in a push to understand returns on investments. Temasek has been invested within the firm since 2017, whereas Warburg Pincus purchased a minority stake in 2021.
By mid-March, personal fairness teams had offloaded a complete of almost $119bn in belongings globally this 12 months, via gross sales or public listings. That is the second-highest degree in 20 years however nonetheless beneath the identical level in 2021 when a increase in sponsor-backed deal exercise resulted in $211bn of exits, in accordance with a Bain evaluation of Dealogic information.
The GHX sale course of was doubtless to attract curiosity from personal fairness teams in addition to strategic patrons, nevertheless it won’t lead to a sale if the funds determined to carry on to the corporate, the individuals mentioned. GHX supplies cloud-based stock, provide chain and cost administration providers for healthcare suppliers and suppliers.
Temasek and Warburg Pincus declined to remark. GHX declined to touch upon “hypothesis” concerning the sale course of, including that the corporate was “targeted on delivering progressive provide chain options that enhance effectivity and cut back prices for healthcare suppliers and suppliers”.
This 12 months, personal fairness teams have managed to engineer some massive exits from software program firms. Warburg Pincus, alongside members of the founding administration staff, absolutely exited a 90 per cent stake in digital well being information firm Modernizing Medicine, promoting to Clearlake Capital in a deal that valued it at $5.3bn, with the personal fairness group realising a virtually 10-fold return on its funding, in accordance with individuals accustomed to the matter.
Thoma Bravo additionally struck a deal to promote vitality software program group Quorum to Francisco Companions for $2.4bn. Blackstone can also be seeking to exit digital well being information firm HealthEdge.
Temasek purchased a stake in GHX from Thoma Bravo in 2017, valuing the enterprise at $1.8bn. Warburg Pincus injected $500mn into the enterprise in 2021, at which level Thoma Bravo absolutely exited its stake.
Temasek has $291bn of belongings in its international funding portfolio, whereas Warburg Pincus has $87bn in belongings below administration.
